150 related articles for article (PubMed ID: 17008297)
1. Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis.
Musaad SM; Melson LC; Boswell RD
Pathology; 2006 Oct; 38(5):473-4. PubMed ID: 17008297
[No Abstract] [Full Text] [Related]
2. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
Parry E; Singh TG; Dow D; Noovao F
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
[TBL] [Abstract][Full Text] [Related]
3. Assessment of rapid fetal fibronectin in predicting preterm delivery.
Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
[TBL] [Abstract][Full Text] [Related]
4. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
5. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al.
Lamont RF; Dragovic B
BJOG; 2006 Jul; 113(7):850-1; author reply 851. PubMed ID: 16827775
[No Abstract] [Full Text] [Related]
7. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET study.
Ugwumadu A; Yanamandra N; Hay P
BJOG; 2006 Jul; 113(7):851-2. PubMed ID: 16827776
[No Abstract] [Full Text] [Related]
8. Predicting preterm delivery: the fetal fibronectin test.
Leeson S; Maresh MJ
Prof Care Mother Child; 1994 Mar; 4(2):38-9. PubMed ID: 8680158
[TBL] [Abstract][Full Text] [Related]
9. Fetal fibronectin.
Koenn ME
Clin Lab Sci; 2002; 15(2):96-8, 115. PubMed ID: 12776771
[TBL] [Abstract][Full Text] [Related]
10. Fetal fibronectin to predict preterm delivery.
French L
J Fam Pract; 1998 Oct; 47(4):250-1. PubMed ID: 9841253
[No Abstract] [Full Text] [Related]
11. Does availability of fetal firbonectin testing in the management of threatened preterm labour affect the utilization of hospital resources?
Abenhaim HA; Morin L; Benjamin A
J Obstet Gynaecol Can; 2005 Jul; 27(7):689-94. PubMed ID: 16100624
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.
Dutta D; Norman JE
J Obstet Gynaecol; 2010; 30(8):768-73. PubMed ID: 21126111
[TBL] [Abstract][Full Text] [Related]
13. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.
Elliott JP; Miller HS; Coleman S; Rhea D; Abril D; Hallbauer K; Istwan NB; Stanziano GJ
J Perinatol; 2005 Oct; 25(10):626-30. PubMed ID: 16107874
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center.
Lowe MP; Zimmerman B; Hansen W
Am J Obstet Gynecol; 2004 Feb; 190(2):358-62. PubMed ID: 14981374
[TBL] [Abstract][Full Text] [Related]
15. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand.
Musaad SM; Melson CL; Boswell DR
Pathology; 2005 Jun; 37(3):226-30. PubMed ID: 16175896
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of fetal fibronectin for predicting preterm birth.
Swamy GK; Simhan HN; Gammill HS; Heine RP
J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
[TBL] [Abstract][Full Text] [Related]
19. [Biochemical markers for preterm delivery (excepting markers of infection)].
Verspyck E; Roman H; Marpeau L
J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7 Suppl):5S35-42. PubMed ID: 12454624
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes.
Yoneda S; Sakai M; Sasaki Y; Shiozaki A; Hidaka T; Saito S
J Obstet Gynaecol Res; 2007 Feb; 33(1):38-44. PubMed ID: 17212664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
